The National prescribing guideline for COPD

A national guideline to standardise prescribing behaviour, with an implementation strategy to reduce clinician barriers to adoption

"Once we get this in place, I believe we will be world leaders in the management of airways disease"

Dr. Simon Barry

National Clinical Lead

The National prescribing guideline for COPD

A national guideline to standardise prescribing behaviour, with an implementation strategy to reduce clinician barriers to adoption

"Once we get this in place, I believe we will be world leaders in the management of airways disease"

Dr. Simon Barry

National Clinical Lead

Solution

A simple, peer-reviewed, hard copy poster with digitial interface and TV show for contextualization, with large-scale learning to maximize adoption.

Benefits

11% saved in the inhaler spend budget

£9 million saved in inhaler spend over 4 years

Joined up with National Standards, Competencies, and Patient self-management Apps

80,000 patients impacted through changes in prescribing behaviours

Solution

A simple, peer-reviewed, hard copy poster with digitial interface and TV show for contextualization, with large-scale learning to maximize adoption.

Copyright © 2020 The Institute of Clinical Science and Technology.

The Institute of Clinical Science and Technology LTD is registered in England and Wales (Company Number 09300292).

VAT Registration Number:206176232

X